International audienceA growing number of infants are exposed to selective serotonin reuptake inhibitor (SSRI) medications during the perinatal period. Perinatal exposure to SSRI medications alter neuroplasticity and increase depressive- and anxiety-related behaviors, particularly in male offspring as little work has been done in female offspring to date. The long-term effects of SSRI on development can also differ with previous exposure to prenatal stress, a model of maternal depression. Because of the limited work done on the role of developmental SSRI exposure on neurobehavioral outcomes in female offspring, the aim of the present study was to investigate how developmental fluoxetine exposure affects anxiety and depression-like behavior,...
Depression during pregnancy and the postpartum period is a growing health problem, which affects up ...
Depression during pregnancy and the postpartum period is a growing health problem, which affects up ...
International audienceWith the growing use of selective serotonin reuptake inhibitor medications (SS...
International audienceA growing number of infants are exposed to selective serotonin reuptake inhibi...
International audienceA growing number of infants are exposed to selective serotonin reuptake inhibi...
A growing number of infants are exposed to selective serotonin reuptake inhibitor (SSRI) medications...
A growing number of infants are exposed to selective serotonin reuptake inhibitor (SSRI) medications...
A growing number of infants are exposed to selective serotonin reuptake inhibitor (SSRI) medications...
Item does not contain fulltextA growing number of infants are exposed to selective serotonin reuptak...
International audienceWith the growing use of selective serotonin reuptake inhibitor medications (SS...
International audienceWith the growing use of selective serotonin reuptake inhibitor medications (SS...
International audienceWith the growing use of selective serotonin reuptake inhibitor medications (SS...
International audienceWith the growing use of selective serotonin reuptake inhibitor medications (SS...
International audienceWith the growing use of selective serotonin reuptake inhibitor medications (SS...
Depression during pregnancy and the postpartum period is a growing health problem, which affects up ...
Depression during pregnancy and the postpartum period is a growing health problem, which affects up ...
Depression during pregnancy and the postpartum period is a growing health problem, which affects up ...
International audienceWith the growing use of selective serotonin reuptake inhibitor medications (SS...
International audienceA growing number of infants are exposed to selective serotonin reuptake inhibi...
International audienceA growing number of infants are exposed to selective serotonin reuptake inhibi...
A growing number of infants are exposed to selective serotonin reuptake inhibitor (SSRI) medications...
A growing number of infants are exposed to selective serotonin reuptake inhibitor (SSRI) medications...
A growing number of infants are exposed to selective serotonin reuptake inhibitor (SSRI) medications...
Item does not contain fulltextA growing number of infants are exposed to selective serotonin reuptak...
International audienceWith the growing use of selective serotonin reuptake inhibitor medications (SS...
International audienceWith the growing use of selective serotonin reuptake inhibitor medications (SS...
International audienceWith the growing use of selective serotonin reuptake inhibitor medications (SS...
International audienceWith the growing use of selective serotonin reuptake inhibitor medications (SS...
International audienceWith the growing use of selective serotonin reuptake inhibitor medications (SS...
Depression during pregnancy and the postpartum period is a growing health problem, which affects up ...
Depression during pregnancy and the postpartum period is a growing health problem, which affects up ...
Depression during pregnancy and the postpartum period is a growing health problem, which affects up ...
International audienceWith the growing use of selective serotonin reuptake inhibitor medications (SS...